Expression of cyclooxygenase-2 in human hyperplastic gastric polyps

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 3, 2003, Pages 425-430

  Bamba, Hiromi ^a,b   Ota, S ^a   Arai, S ^a   Ban, S ^a   Shimizu, M ^a   Imai, Y ^a   Kawamoto, C ^a   Yoshida, Y ^a   Fujiwara, K ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

COX 2; Hyperplastic gastric polyp; Mesenchymal cell

Indexed keywords

ALPHA ACTIN; CD68 ANTIGEN; CYCLOOXYGENASE 2;

ARTICLE; DISEASE ASSOCIATION; ENDOSCOPIC POLYPECTOMY; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MESENCHYME CELL; MYOFIBROBLAST; PRIORITY JOURNAL; STOMACH CARCINOGENESIS; STOMACH POLYP; TUMOR LOCALIZATION;

AGED; AGED, 80 AND OVER; CYCLOOXYGENASE 2; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYPS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STOMACH;

EID: 0141670390     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hentschel E., Brandstatter G., Dragosics B., et al.: Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N. Engl. J. Med. 328: 308-12, 1993.
2. Sung J.J., Chung SC, Ling T.K., et al.: Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N. Engl. J. Med. 332: 139-42, 1995.
3. Uemura N., Okamoto S., Yamamoto S., et al.: Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345: 784-789, 2001.
4. Veereman Wauters G, Ferrell L., Ostroff J.W., Heyman M.B.: Hyperplastic gastric polyps associated with persistent Helicobacter pylori infection and active gastritis. Am. J. Gastroenterol. 85: 1395-1397, 1990.
5. Mocek F.W., Ward W.W. Jr., Wolfson S.E., Rumage W.T. Jr., Wieman T.J.: Elimination of recurrent hyperplastic polyps by eradication of Helicobacter pylori. Ann. Intern. Med. 120: 1007-1008, 1994.
6. Nakajima A., Matsuhashi N., Yazaki Y., Oka T., Sugano K.: Details of hyperplastic polyps of the stomach shrinking after anti-Helicobacter pylori therapy. J. Gastroenterol. 35: 372-375, 2000.
7. Ohkusa T., Takashimizu I., Fujiki K., et al.: Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. Ann. Intern. Med. 129: 712-715, 1998.
8. Saito Y., Ohkusa T., Endo S., Okayasu I.: Detection of Helicobacter pylori in gastric hyperplastic polyps: comparison between foveolar and fundic polyps. Eur. J. Gastroenterol. Hepatol. 4: S89-S92, 1992
9. Romano M., Ricci V., Memoli A., et al.: Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro. J. Biol. Chem. 273: 28560-28563, 1998.
10. Fu S., Ramanujam K.S., Wong A., et al.: Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 116: 1319-1329, 1999.
11. Gupta R.A., Dubois R.N.: Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nature Rev. Cancer. 1: 11-21, 2001.
12. Bamba H, Ota S, Kato A, Adachi A, Itoyama S, Matsuzaki F.: High expression of cyclooxygenase-2 in macrophages of human colonic adenoma. Int. J. Cancer. 83: 470-475, 1999.
13. Debongnie J.C.: Gastric polyps. Acta., Gastroenterol., Belg. 62: 187-189, 1999.
14. McCarthy C.J., Crofford L.J., Greenson J., Scheiman J.M.: Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection. Am. J. Gastroenterol. 94: 1218-1223, 1999.
15. Tatsuguchi A., Sakamoto C., Wada K., et al.: Localization of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans. Gut 46: 782-789, 2000.
16. Chan F.K., To K.F., Ng Y.P., et al: Expression and Cellular localization of COX-1 and -2 in Helicobacter pylori gastritis. Aliment. Pharmacol. Ther. 15: 187-193, 2001
17. Giardiello F.M., Hamilton S.R., Krush A.J., et al.: Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med. 328: 1313-1316, 1993.
18. Steinbach G., Lynch P.M., Phillips R.K., et al.: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med. 342: 1946-1952, 2000.
19. Majima M., Hayashi I., Muramatsu M., Katada J., Yamashina S., Katori M.: Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br. J. Pharmacol. 130: 641-964, 2000.
20. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., DuBois R.N.: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705-719, 1998.
21. Bamba H., Ota S., Kato A., Kawamoto C., Fujiwara K.: Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells. Biochem. Biophys. Res. Commun. 273: 485-491, 2000.
22. 1 on vascular endothelial growth factor production by human macrophages and colon cancer cells. J. Exp. Clin. Cancer Res. 19: 219-223, 2000.